| Histological Diagnosis |
Site of Primary |
Frequency |
Percentage |
| Adenocarcinoma |
Breast |
65 |
28.3% |
| Adenocarcinoma |
Gastrointestinal (colorectal) |
64 |
27.8% |
| Adenocarcinoma |
Prostate |
4 |
1.7% |
| Adenocarcinoma |
Pancreas |
3 |
1.3% |
| Cholangiocarcinoma |
Bile ducts |
1 |
0.4% |
| Serous adenocarcinoma |
Ovary |
2 |
0.9% |
| Urothelial carcinoma |
Kidney |
20 |
8.7% |
| Papillary carcinoma |
Thyroid |
10 |
4.3% |
| Melanoma |
Skin |
16 |
7.0% |
| Squamous cell carcinoma |
Skin |
1 |
0.4% |
| Squamous cell carcinoma |
Base of tongue |
1 |
0.4% |
| Squamous cell carcinoma |
Cervix |
2 |
0.9% |
| Squamous cell carcinoma |
Esophagus |
1 |
0.4% |
| Endometrioid carcinoma |
Endometrium |
3 |
1.3% |
| Endometrial stromal sarcoma |
Endometrium |
4 |
1.7% |
| Leiomyosarcoma |
Uterus |
3 |
1.3% |
| Leiomyosarcoma |
Inferior vena cava |
1 |
0.4% |
| Leiomyosarcoma |
Left leg |
2 |
0.9% |
| Seminoma |
Testicle |
2 |
0.9% |
| Embryonal Carcinoma |
Testicle |
2 |
0.9% |
| Rhabdomyosarcoma |
Testicle |
1 |
0.4% |
| Adenoid Cystic Carcinoma |
Salivary gland- parotid |
1 |
0.4% |
| Metastasizing pleomorphic adenoma |
Salivary gland-submandibular |
1 |
0.4% |
| Osteosarcoma |
Femur |
4 |
1.7% |
| Chondrosarcoma |
Right Femur |
2 |
0.9% |
| Ewing’s sarcoma |
Chest wall mass |
2 |
0.9% |
| Hepatocellular carcinoma |
Liver |
2 |
0.9% |
| Neuroblastoma |
Adrenal |
1 |
0.4% |
| Malignant peripheral nerve sheath tumour |
Right neck |
2 |
0.9% |
| Malignant Mesothelioma |
Mesothelium |
1 |
0.4% |
| Liposarcoma |
Thigh |
1 |
0.4% |
| Chordoma |
Spine |
1 |
0.4% |
| Undifferentiated high-grade malignancy- poorly differentiated adenocarcinoma |
Breast , colon, ovary, thyroid, kidney, prostate or GI |
4 |
1.7% |
| TOTAL |
230 |
100% |